Bynd Cannasoft Enterprises Inc. Announces $649,500 Unbrokered Private Loan, The Canadian Business Journal

VANCOUVER, British Columbia, September 30, 2022 (GLOBE NEWSWIRE) — BYND Cannasoft Enterprises Inc. (Nasdaq: BCAN) (CSE: BYND) (“BYND” or “Company”) announces that it has agreed to raise up to C$649,500 in an unbroken private placement from selected investors. Specifically, the Company has agreed to issue up to 150,000 shares of its common stock at an issue price of $4.33 per share (“private placement”).

The private placement is expected to close by the end of October and is subject to receipt of all required regulatory approvals. At the investor’s request, proceeds from the private placement will be used to pay for public relations, investor relations, and marketing expenses for the business.

There is no brokerage fee for private placements. Pursuant to the Canadian Securities Act, all shares of common stock issued under the Private Placement are subject to a hold period of four months plus one day from the closing date of the Private Placement. The common stock will be offered only to investors located in Israel. No securities will be offered or sold in the United States or to US investors.

BYND CEO Yftah Ben Yaackov said: A global company that helps create real value for shareholders and the company. ”

About BYND Cannasoft Enterprises Inc.

BYND is an integrated software/cannabis company based in Israel.

CRM software

BYND owns and sells its own Customer Relationship Management (CRM) software product known as “Benefit CRM”. BYND’s Benefit CRM software enables small businesses to optimize their daily operations such as sales management, human resources management, marketing, call center activities and asset management. BYND’s next-generation Benefit CRM platform is now ready for beta testing.

Cannabis CRM

Based on 20 years of experience in CRM software, BYND recently started developing a revolutionary new CRM platform specifically designed to serve the needs of the medical cannabis industry. This new platform is a first in the medical cannabis space and we believe it will transform the industry into a more organized, accessible and price transparent marketplace. The data and information collected through the operation of the Cannabis Farm (see below) and the products it produces will allow BYND to test the new Cannabis CRM Platform and adjust the Platform as necessary. Additionally, operating a cannabis farm and selling medical cannabis will provide additional revenue to further support BYND during the initial rollout period of the Cannabis CRM platform.

cannabis farm

BYND is in the process of securing approval for the transfer of a primary cultivation license to grow medical cannabis in Israel and plans to build a 3.7-acre farm facility near Ashkelon Israel to grow medical cannabis. is. The company’s plans include the construction of four of his state-of-the-art greenhouses, which house approximately 2.5 acres of total growing area. BYND estimates that once the cannabis farm facility is fully operational, it can produce 7,500kg of raw cannabis each year. BYND will also work with strategic partners to develop and market new proprietary cannabis-infused products for sale and export throughout Israel. For more information, see our website www.cannasoft-crm.com, CSE’s website www.thecse.com/en/listings/life-sciences/bynd-cannasoft-enterprises-inc and the information available on SEDAR. please refer to. : www.sedar.com.

Gabi Cabazo
CFO
Phone: (604) 833‐6820
Email: [email protected]-crm.com

For media and investor information, please contact:
David L. Kugelman
(866) 692-6847 Toll Free – USA and Canada
(404) 281-8556 Mobile and WhatsApp
[email protected]
Skype: Kugusa

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements that involve risks and uncertainties, and actual results may differ materially from those described. As used in this document, “may”, “could”, “could”, “will”, “intend”, “plan”, “forecast”, “believe ”, “estimate”, “expect” and similar expressions are intended to identify forward-looking statements. In this news release, these statements include, but are not limited to, the anticipated completion of the private placement and intended use of proceeds from the private placement. Such statements reflect our current views regarding future events and are subject to such risks and uncertainties. Many factors could cause our actual results to differ materially from the published statements. This includes, but is not limited to, our acceptance of private placement subscriptions and our existing business terms at the time of our intentional use of net proceeds from private placements. Factors explained in our filings with Canadian securities regulators and the U.S. Securities and Exchange Commission. In the event that one or more of these risks and uncertainties, such as fluctuations in currency or interest rates, increased competition, general economic or market factors, occurs or the assumptions underlying the forward-looking statements are not correct. If not, actual results could differ materially from those stated herein. Intended, planned, anticipated, or expected. We disclaim any intention or obligation to update these forward-looking statements, except as required by law. Shareholders are cautioned not to place undue reliance on such forward-looking statements.

Neither the US Securities and Exchange Commission nor the CSE have confirmed, approved or disapproved of the contents of this press release.

CBJ Newsmaker